$CL

Colgate-Palmolive Q3 Earnings Call Highlights

Colgate-Palmolive (CL) reported Q3 earnings, noting elevated commodity and logistics costs. Hill's Pet Nutrition saw 6.5% organic sales growth, driven by cat food and wet food. U.S. toothpaste market share shows early improvement. Latin America grew 6%, with Brazil up double digits. Asia-Pacific rose 5%, led by India. Full-year cost inflation is estimated at $300M. The company plans to provide 2027 guidance in Q1 next year.

Original reporting
Published Oct 30, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Colgate-Palmolive Q3 Earnings Call Highlights — source image
Decision brief

The 30-second read

$CLNeutralHigh
01

Why it matters

The earnings call provides fresh guidance on cost inflation and commodity pressure, which are key drivers for the sector's near‑term performance.

02

Market read

The new cost‑inflation guidance may prompt a short‑term re‑rating of CL and peers in the consumer staples space.

03

What to watch

AI‑driven advertising efficiency and the rollout of Fresh pet diets may offset some cost headwinds.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Colgate-Palmolive (NYSE:CL) is a large‑cap consumer products company with exposure to commodity inputs and global currency fluctuations.

Company-level read

Ticker impact

$CLNeutralHigh confidence
Context

Colgate-Palmolive disclosed Q3 results and full-year cost inflation of roughly $300 million, plus elevated commodity pressure guidance for Q4.

Expected impact

likely pressure as the market prices in higher cost and commodity inflation

Evidence & confidence

Guidance shows cost inflation remaining high and tariffs peaking, which could compress margins despite revenue growth.

Market effects

Consumer staples may face margin pressure from rising commodity costs, prompting analysts to reassess cost‑inflation assumptions.

U.S. oral‑care segment sees modest share‑gain, but Latin America and Asia‑Pacific growth may be tempered by currency volatility.

Highlights broader inflationary pressures affecting multiple consumer‑goods companies worldwide.

Counterpoint

Despite cost inflation, the company's pricing power and premium innovation could sustain earnings momentum.

Key entities

  • Colgate-Palmolive

    Global consumer products firm reporting Q3 results.

Related articles

$CLMed

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.

$CLMedAI 8/10

Wells Fargo raises Colgate-Palmolive stock price target on solid Q3

Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.

$CLMed

UBS raises Colgate-Palmolive stock price target on margin strength

UBS raised its price target for Colgate-Palmolive (CL) to $112 from $106, citing strong Q3 earnings, revenue, and margins. The company beat EPS estimates and raised 2026 guidance. UBS expects continued sales growth despite inflation and FX headwinds, though the stock is slightly overvalued. CL reported Q3 adjusted EPS of $0.97 on revenue of $5.37B, exceeding expectations.

$CLMed

Colgate-Palmolive Co (CL) (Q3 2026) Earnings Call Highlights: Broad-Based Organic

Colgate-Palmolive (CL) reported Q3 2026 earnings, highlighting 6.5% organic growth in Hills pet food and strong volume leverage. CEO Noel Wallace attributed margin gains to pricing, innovation, and ad spend efficiency. CFO Stan Sutula noted material cost headwinds offset by productivity and pricing. Latin America grew 6%, with Brazil up double-digits. US toothpaste showed slight improvement, with more pricing expected.

$CLHighAI 8/10

Colgate-Palmolive Company Q3 2026 Earnings Call Summary

Colgate-Palmolive reported Q3 2026 earnings, highlighting organic growth in emerging markets and Europe. Gross margin expansion was driven by pricing strategy and manufacturing leverage. The company is transitioning its U.S. go-to-market structure and integrating AI for revenue growth. Hill's Pet Nutrition saw strong performance in high-growth segments.